Showing 2351-2360 of 3329 results for "".
- Revance Highlights RHA Dynamic Volume Mid-Face FDA Approval at Virtual Desk Sidehttps://modernaesthetics.com/news/revance-highlights-rha-dynamic-volume-mid-face-fda-approval-at-virtual-desk-side/2486819/Revance Aesthetics hosted a virtual desk side with Lesley Clark-Loeser, MD, to discuss the recent US Food and Drug Administration (FDA) approval of RHA Dynamic Volume for cheek augmentation and correction of age-related mid-face contour deficiencies in adults aged 22 years and older. The a
- Epicutis Reports 8-Week Clinical Findings for New Hydrobiome Serumhttps://modernaesthetics.com/news/epicutis-reports-8-week-clinical-findings-for-new-hydrobiome-serum/2486634/Epicutis has introduced Hydrobiome Serum, a new professional skincare product positioned for redness, congestion, and barrier disruption. The formulation centers on TCP, a proprietary isoprenyl cysteine compound developed by Signum Biosciences, and is paired with sodium tocopheryl phosphate, a wa
- Paper: AI Gains Ground in Cosmetic Dermatology Workflowshttps://modernaesthetics.com/news/paper-ai-gains-ground-in-cosmetic-dermatology-workflows/2486551/A recent review in Dermatology and Therapy assessed the growing use of artificial intelligence (AI) across aesthetic dermatology, with the authors reporting increased adoption and highlighting its use in many aspects of prac
- Molecular Profiling Reveals Personalized Pathways in Skin Aginghttps://modernaesthetics.com/news/molecular-profiling-reveals-personalized-pathways-in-skin-aging/2486451/A translational biomarker study presented at the American Academy of Dermatology (AAD) 2026 Annual Meeting highlighted distinct molecular signatu
- AAD 2026: Allergan Aesthetics Highlights TrenibotE Data and GLP-1 RA Patient Trendshttps://modernaesthetics.com/news/aad-2026-allergan-aesthetics-highlights-trenibote-data-and-glp-1-patient-trends/2486432/Allergan Aesthetics, an AbbVie company, presented four posters at the 2026 American Academy of Dermatology (AAD) Annual Meeting in Denver, Colorado, including new findings on repeat treatment with investigational trenibotulinumtoxinE (TrenibotE) and insights into aesthetic trends among patients r
- AAD 2026: Lumenis Launches triLIFT 2.0 for Combined Muscle and Skin Rejuvenationhttps://modernaesthetics.com/news/lumenis-launches-trilift-20-for-combined-muscle-and-skin-rejuvenation/2486430/Lumenis Be Ltd. announced the commercial launch of triLIFT 2.0, a next-generation platform designed to deliver combined muscle stimulation and skin rejuvenation for facial and body applications. The system integrates Dynamic Muscle Stimulation technology (DMSt) with FibroBoost, aiming to address
- AAD 2026: CO2 Laser Resurfacing Linked to Transient Microbiome Shiftshttps://modernaesthetics.com/news/aad-2026-co2-laser-resurfacing-linked-to-transient-microbiome-shifts/2486399/New findings presented at the 2026 American Academy of Dermatology (AAD) Annual Meeting in Denver, Colorado, provide insight into dynamic microbiome changes following ablative CO2 laser resurfacing and their relationship to wound healing. In this monocentric, double-blind, rando
- New Skin Quality Index Aims to Align Patient–Provider Communication in Aestheticshttps://modernaesthetics.com/news/new-skin-quality-index-aims-to-align-patientprovider-communication-in-aesthetics/2486112/Allergan Aesthetics, an AbbVie company, announced the launch of the Skin Quality Index (SQI), a new framework designed to standardize how patients and health care providers discuss skin quality during aesthetic consultations. The initiative is supported by global research published in Dermato
- Photocurable Collagen Filler Aims to Address Weight-Loss–Associated Facial Deflationhttps://modernaesthetics.com/news/photocurable-collagen-filler-aims-to-address-weight-lossassociated-facial-deflation/2485851/CollPlant Biotechnologies announced the strategic positioning of its photocurable dermal filler platform to address facial volume loss associated with rapid weight reduction, including in patients treated with glucagon-like peptide-1 receptor agonists (GLP-1 RA) for metabolic health and weight ma
- Octane Aesthetics Tech Forum: Strategy Over Syringes Leads 2025 Filler Reboundhttps://modernaesthetics.com/news/octane-aesthetics-tech-forum-strategy-over-syringes-leads-2025-filler-rebound/2485717/“Flipping the Filler Script” was a hot topic at the 2026 Octane Aesthetics Tech Forum held January 8 and 9 in Newport Beach, California. The panel was moderated by Jason D. Bloom, MD, FACS, of Bloom Facial Plastic Surgery in Bryn Mawr, Pennsylvania, and panelists included Shawna Chrisman, NP, Chi